Patents by Inventor Olivér ÉLIÁS

Olivér ÉLIÁS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BICYCLIC AMINE DERIVATIVES AS GABAA alpha5 RECEPTOR MODULATORS
    Publication number: 20250051323
    Abstract: The present invention provides compounds of formula (I) and/or salts thereof and/or stereoisomers thereof and/or enantiomers thereof and/or racemates thereof and/or diastereomers thereof and/or biologically active metabolites thereof and/or prodrugs thereof and/or solvates thereof and/or hydrates thereof and/or polymorphs thereof having affinity and selectivity for the gamma-aminobutyric acid A receptor subunit alpha 5 and act as GABAA ?5 positive allosteric modulators, thereby useful in the treatment or prevention of diseases related to the GABAA ?5 receptor, process for the preparation and intermediates of the preparation process thereof, pharmaceutical compositions comprising them alone or in combination with one or more other active ingredients and their use as medicaments.
    Type: Application
    Filed: September 28, 2022
    Publication date: February 13, 2025
    Inventors: György SZABÓ, Attila POTOR, Péter ERDÉLYI, Imre BATA, György István TÚRÓS, Gábor László KAPUS, Olivér ÉLIÁS
  • NAPHTHYRIDINE AND PYRIDO[3,4-c]PYRIDAZINE DERIVATIVES AS GABAA ALPHA 5 RECEPTOR MODULATORS
    Publication number: 20240067637
    Abstract: The present invention provides compounds of formula (I) and/or salts thereof and/or biologically active metabolites thereof and/or prodrugs thereof and/or solvates thereof and/or hydrates thereof and/or polymorphs thereof having affinity and selectivity for the gamma-aminobutyric acid A receptor subunit alpha 5 and act as GABAA ?5 positive allosteric modulators, thereby useful in the treatment or prevention of diseases related to the GABAA ?5 receptor, process for the preparation and intermediates of the preparation process thereof, pharmaceutical compositions comprising them alone or in combination with one or more other active ingredients and their use as medicaments.
    Type: Application
    Filed: March 25, 2021
    Publication date: February 29, 2024
    Inventors: György SZABÓ, Attila POTOR, István VÁGÓ, György István TÚRÓS, Olivér ÉLIÁS, Gábor László KAPUS
  • BICYCLIC DERIVATIVES AS GABAA A5 RECEPTOR MODULATORS
    Publication number: 20210386718
    Abstract: The present invention provides compounds of formula (I) and/or salt thereof and/or geometric isomer thereof and/or stereoisomer thereof and/or enantiomer thereof and/or racemate thereof and/or diastereomer thereof and/or biologically active metabolite thereof and/or prodrug thereof and/or solvate thereof and/or hydrate thereof and/or polymorph thereof having affinity and selectivity for the gamma-aminobutyric acid A receptor subunit alpha 5 and act as GABAA ?5 negative allosteric modulators, thereby useful in the treatment or prevention of diseases related to the GABAA ?5 receptor, process for the preparation thereof, pharmaceutical compositions comprising them alone or in combination with one or more other active ingredients and their use as medicaments.
    Type: Application
    Filed: September 27, 2019
    Publication date: December 16, 2021
    Inventors: GYORGY SZABO, György István TÚRÓS, Olivér ÉLIÁS, Benedek Imre KÁROLYI, Péter ERDÉLYI, Gábor KAPUS